Mark DeLong
Corporate Officer/Principal bei APELLIS PHARMACEUTICALS, INC.
Vermögen: 3 Mio $ am 30.04.2024
Profil
Mark DeLong is currently the Chief Business & Strategy Officer at Apellis Pharmaceuticals, Inc. He previously worked at EMD Serono, Inc. as the Head of Business Development from 2007 to 2018.
Mr. DeLong completed his undergraduate degree at The Pennsylvania State University and holds an MBA from the University of Michigan.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.03.2024 | 54 693 ( 0,05% ) | 3 Mio $ | 30.04.2024 |
Aktive Positionen von Mark DeLong
| Unternehmen | Position | Beginn |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.02.2018 |
Ehemalige bekannte Positionen von Mark DeLong
| Unternehmen | Position | Ende |
|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01.01.2018 |
Ausbildung von Mark DeLong
| The Pennsylvania State University | Undergraduate Degree |
| University of Michigan | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
